OTC · ORHB
ORHub, Inc.
$0.01$0.00 (0.0%)
ORHub, Inc.’s quoted price sits in the upper half of its reported 52-week range, 40.0% below the high.
Loading market information…
OTC · NHEL · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Natural Health Farm Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Natural Health Farm Holdings Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Natural Health Farm Holdings Inc. (NHEL) is a biotechnology firm currently in its developmental phase, concentrating its efforts on creating a healthcare system rooted in natural and naturopathic remedies. The company, originally incorporated as Amber Group, Inc., officially adopted the name Natural Health Farm Holdings Inc. in March 2017. Established in 2014, its primary operations are based in Rawang, Malaysia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:08 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
ORHub, Inc.’s quoted price sits in the upper half of its reported 52-week range, 40.0% below the high.
$0.00$0.00 (0.0%)
Medixall Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 41.07% below the high.
$0.00$0.00 (0.0%)
Founders Bay Holdings’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Stem Cell Authority, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 98.67% below the high.
$0.00$0.00 (0.0%)
Scopus BioPharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.0% below the high.
$0.00$0.00 (0.0%)
Regenicin, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.99% below the high.
$0.00$0.00 (0.0%)
Medite Cancer Diagnostics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Ceres Ventures, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
